Capital Markets

NeuroTrader capital markets edition, in development.

DEMONSTRATION LISTING
Overview
Category
Financial Intelligence
Stage
Development
Illustrative Modeled Value
$7.3M
ARR (illustrative)
Pre-revenue

Confidential materials (financials, code, contracts) are shared only after NDA in a deal room. Figures are illustrative, not appraisals or verified results.

Commercial options
ILLUSTRATIVE / NOT AN ACTIVE OFFERINGEducational demonstration. No securities are offered, no investments accepted, no funds transferred. Any future offering would follow the applicable exemption, legal approval and, where required, an authorised intermediary.
Preferred equity · hypothetical
ILLUSTRATIVE

Issuing entity: to be formed — no issuer exists today. Every figure below is a modeled assumption, not an offer.

Post-money
$5.0M
Illustrative ownership
10.0%
Annual preferred return
$40K

Pre-money → post-money · modeled

Founder ownership and dilution · modeled %

Ownership after investment (modeled)
■ Founder 90.0%■ Investor A 6.0% · Investor B 4.0%
Capitalization table and draft investor rights
Cap table (illustrative)OwnershipClass
Founder / common90.0%Common
Investor A (illustrative)6.0%Preferred · 1× non-participating
Investor B (illustrative)4.0%Preferred · 1× non-participating
Draft term sheet summary
  • Instrument: non-voting preferred equity
  • Liquidation preference: 1× non-participating
  • Preferred return: 8% per annum (illustrative)
  • Anti-dilution: broad-based weighted average (draft)
  • Board: founder-controlled; investor observer seat
Use of proceeds (illustrative)
  • Product development45%
  • Go-to-market25%
  • Team20%
  • Working capital10%

Investor rights (information, protective provisions, pro-rata) would be defined in definitive documents reviewed by counsel. Non-voting preferred does not by itself remove investor protective rights; every instrument is reviewed against the founder's control structure. Dilution from future rounds is not modeled here.

Financing preparation

No issuer or active offering
  1. Issuer evidence
  2. Cap table
  3. Draft terms
  4. Legal review
  5. Authorized execution
1 / 5Issuer evidenceNo issuer or active offering

Investment inquiries are not accepted while capital formation is disabled.